Statistics for Relacorilant, a Selective Glucocorticoid Receptor Modulator, Induces Clinical Improvements in Patients With Cushing Syndrome: Results From A Prospective, Open-Label Phase 2 Study
Total visits
views | |
---|---|
Relacorilant, a Selective Glucocorticoid Receptor Modulator, Induces Clinical Improvements in Patients With Cushing Syndrome: Results From A Prospective, Open-Label Phase 2 Study | 66 |
Total visits per month
views | |
---|---|
May 2024 | 0 |
June 2024 | 0 |
July 2024 | 0 |
August 2024 | 0 |
September 2024 | 0 |
October 2024 | 0 |
November 2024 | 0 |
File Visits
views | |
---|---|
fendo-12-662865.pdf | 23 |
Top country views
views | |
---|---|
United States | 51 |
Sweden | 3 |
India | 2 |
South Korea | 1 |
Malaysia | 1 |
Russia | 1 |
Top city views
views | |
---|---|
Wilmington | 41 |
Lake Mary | 3 |
Malmö | 3 |
San Francisco | 3 |
Ann Arbor | 1 |
Bengaluru | 1 |
Cambridge | 1 |
Delhi | 1 |
Kemerovo | 1 |
Kuala Lumpur | 1 |
Washington | 1 |